natürliche glp 1 agonisten Mapping the effectiveness and risks of GLP-1 receptor agonists GLP-1 natürlich fördern, ohne Medikamente
Description
Looking toward the future, one has only to look at www.ClincalTrials.gov to see the many studies underway and planned for these drugs
Brchers S, Skibicka KP
111 The only acceptable alternative endpoint in drug development, histological evidence, consists of the resolution of steatohepatitis and no worsening of liver fibrosis, or improvement in liver fibrosis of at least one stage without worsening of steatohepatitis
Chen Y, Chou K, Fuchs E, Havran WL, Boismenu R
10.3390/jcm10050985 [DOI] [PMC free article] [PubMed] [Google Scholar] 174.Unni S, Wittbrodt E, Ma J, Schauerhamer M, Hurd J, Ruiz-Negrn N, et al
2018 Dec;108:952-962
